SSc fibroblasts expressed mRNA for P2X3, P2X4, P2X7, P2Y1, P2Y2, P2Y4, and P2Y6, suggesting a possible therapeutic role for P2R antagonists in SSc patients via modulation of fibroblast function. The gene discussed is P2RX4; the disease is systemic sclerosis.